Navigation Links
Formatta Presents Forms-Driven Business Process Optimization Webinar for Healthcare on Thursday, November 19 at 1 p.m. Eastern
Date:11/3/2009

Formatta Forms Optimization Solution Enables Organizations To Drive Down Costs While Providing Better Patient Care

Fairfax, VA (Vocus) November 3, 2009 -- Formatta, a leading provider of e-forms data capture and integration software solutions, today announced “Formatta Forms Optimization Solution Enables Organizations To Drive Down Costs While Providing Better Patient Care” a free webinar on November 19 for healthcare providers interested in learning how to quickly, easily and affordably e-enable paper forms and unlock the data for integration with hospitals, other healthcare facilities and department systems.

Today’s healthcare providers face intense economic and competitive pressures. Clinics, urgent care facilities, and nursing homes are overwhelmed by inefficient and duplicative processes resulting from paper-based forms. The critical information trapped on paper does not efficiently make its way to the applications that need it most.

What: Learn how Formatta’s forms optimization solution helps healthcare organizations create competitive advantage through reduced costs, streamlined operations, compliance assistance and, ultimately, increased overall patient satisfaction. Formatta optimized e-forms allow faster response to patient, payer and provider requests.

When: Thursday, November 19

Time: 1:00PM EST

Where: http://www.f
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Formatta Presents Forms-Driven Business Process Optimization Webinar for Healthcare on Wednesday, October 14 at 1 p.m. Eastern
2. INFORMS presents 11 new Fellows Awards
3. NeoVista Presents Interim Study Results of Novel Therapy for the Treatment of Neovascular Age-Related Macular Degeneration
4. Morehead Presents Webinar on 'A Two-Pronged Strategy to Reduce Nurse Turnover'
5. Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk
6. YWCA Greater Los Angeles Presents Black & White Benefactrix Ball
7. Hospice Foundation of America Presents Webinar on Grief, Holidays, and Family Dynamics
8. CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis
9. Morehead Presents Webinar on "Measuring the Organization's Patient Safety Culture"
10. Simmons Law Firm Presents Second Miles for Meso Walk/Run Fundraiser for Mesothelioma Research
11. Simmons Law Firm Presents Second Miles for Meso Walk/Run Fundraiser

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Formatta Presents Forms-Driven Business Process Optimization Webinar for Healthcare on Thursday, November 19 at 1 p.m. Eastern 
Formatta Presents Forms-Driven Business Process Optimization Webinar for Healthcare on Thursday, November 19 at 1 p.m. Eastern
(Date:11/21/2009)...ill provides for an unprecedented expansion of fed...if it is not for preserving and protecting human l...ed." Charmaine Yoest ,, WASHINGTON, Nov. 21 ...fe Action President and CEO Dr. Charmaine Yoest re...ng the following statement: ,, "This was a pro...
(Date:11/21/2009)... NH based medical credentialing software company... form a partnerhsip with Amerinet, Inc., the leadi... will help to transform quality care within the he...) November 21, 2009 -- ISG Group, LLC, doing busin...ement with Amerinet Inc., a leading national healt...
(Date:11/21/2009)... Linwood Group ask whether there is a secret to ... London, UK (PRWEB) Novemb...o one in three of the adult UK population drinking...ohol-related liver disease*, it is hardly a surpri...ation programmes and residential centres for help....
(Date:11/20/2009)...., Nov. 20 Following a recall by U...moved from sale Shedd,s Country Crock ® Side ...untry Crock ® Side Dishes DELUXE Four Cheese ..., The following code dates and UPCs are affected: ...LUXE Cheddar Broccoli Rice 21 oz, UPC 027400218316...
(Date:11/20/2009)..., Israel, November 20 Ca...p://www.CVSLMEDICAL.COM , a leading,developer of a...nnounced that,the company,s Board of Directors has..., Canada and the Far East for its proprietary next...ll angioplasty (PCTA) procedures. , Cardi...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...tients to be remotely monitored through XTend,s Di..., SUN VALLEY, Calif., Feb. 14 XTend Medical,Corp...mpany has begun a,remote diabetic monitoring progr...emotely monitor diabetic patients through the XTen...
...nvestments Totaled Approximately $2.2 Billion, Ven...o Range between $2.75 ...S EIGHT PERCENT TO $0.5125 PER SHARE, LOUISVILLE,...d common share rose ten percent to,$2.69, compared...
...ferers Can Enjoy a Romantic Valentine,s Day With ...LE, Feb. 13 , WHO: The 60 million Americans... don,t have to worry about a painful sore deraili... adhesive patch, has been shown in a peer-re...
...exico, among the choices for 2008, SEATTLE, Feb. ...lcanoes of Mexico" -- highlights the 2008 Climb to... Cancer Research Center., The 11th annual Climb h...,343 feet). Both trips will be led by,professional...
...3 Matrixx Initiatives, Inc.,(Nasdaq: MTXX ), an ...and,markets products that provide consumers with "...on Wednesday February 20, 2008, at the Roth,Capita... http://www.matrixxinc.com . Interested parties,sh...
...Feb. 13 Valentine,s Day is,not just for lovers. T...ers, St. Valentine, takes on greater meaning when ...sy -- a common neurological condition that,causes ...Valentine is connected to epilepsy because,the nam...
Other Medicine News:Health News:XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program 2Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 2Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 3Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 4Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 5Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 6Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 7Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 8Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 9Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 10Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 11Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 12Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 13Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 14Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 15Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 16Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 17Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 18Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 19Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 20Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 21Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 22Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 23Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 24Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 25Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 26Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 27Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 28Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 29Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 30Health News:Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69 31Health News:Pucker Up Without the Pain 2Health News:Climb to Fight Breast Cancer Offers Peaks for Every Skill Level 2Health News:Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference 2
(Date:11/20/2009)...-- ,, Reportlinker.com announces that a new mar... ,, Global Markets for Breast Biopsy Devices 2...Global-Markets-for-Breast-Biopsy-Devices-2009.html...ampaign=prnewswire ,, The global markets for ...ore needle market and vacuum assisted breast biops...
(Date:11/20/2009)...tCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ...utive Officer, and Greg Browne, Chief Financial Of...ay Health Care Conference in New York on Wednesday...e session and webcast will be audio only and no fo... host a webcast of the presentation live and by re...
(Date:11/19/2009).../ -- Warner Chilcott plc (Nasdaq: WCRX ) today an...condary offering of 20,000,000 of its ordinary sha... The selling shareholders include funds affiliated... J.P. Morgan Partners (advised by CCMP Capital) an...itutional investors and members of the Company,s s...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Placental precursor stem cells require testosterone free environment to survive 10574 1Placental precursor stem cells require testosterone free environment to survive 10574 2American Physiological Society endorses report on random source dogs and cats 10569 1American Physiological Society endorses report on random source dogs and cats 10569 2American Physiological Society endorses report on random source dogs and cats 10569 3The Breema Center Offers Bodywork Mini Sessions and Demonstrations at the San Francisco Green Festival 60315 1The Breema Center Offers Bodywork Mini Sessions and Demonstrations at the San Francisco Green Festival 60315 2
...t from,Schering-Plough, Roche today affirmed the v...ination with ribavirin as the market-leading,treat...States and globally.,Despite clear biases in the d...d patients taking Peg-Intron(TM) (peginterferon al...reduction protocol - the study results have,shown ...
...ay, SOUTH SAN FRANCISCO, Calif., Jan. 14 Cell,Ge...the Independent Data,Monitoring Committee (IDMC) f...cal trials of GVAX immunotherapy for prostate canc...nd has recommended that the study continue.,This e...mine whether the,study should continue to completi...
Other Medicine Technology:Roche responds to announcement of 'IDEAL' hepatitis C trial results 2Roche responds to announcement of 'IDEAL' hepatitis C trial results 3Roche responds to announcement of 'IDEAL' hepatitis C trial results 4Roche responds to announcement of 'IDEAL' hepatitis C trial results 5Roche responds to announcement of 'IDEAL' hepatitis C trial results 6Roche responds to announcement of 'IDEAL' hepatitis C trial results 7Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 2Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 3Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 4
Aaron 800-EU
Sabre 180, 100V, 50Hz/60Hz
Sabre 2400, 240V, 50Hz
Sabre 2400, 110V, 60Hz
Medicine Products: